Mapping of Routine Coronavirus Vaccination 2019 in Tshopo Province, DR Congo, July to December 2021

Abstract

The new 2019 coronavirus (Covid-19), recently known as "SARS-CoV-2" by the International Committee on Virus Taxonomy, is a beta-coronavirus, homologous to the bat coronavirus and closely related to SARS-CoV. outside of medical care of Covid-19 symptoms, vaccination is one of the most effective means of providing lasting protection for humans. This descriptive-cross-sectional study included 3 886 persons vaccinated in routine vaccination mode in the 2 sites: Makiso-Kisangani General Reference Hospital and the Kisangani fiftieth anniversary hospital in the Makiso-Kisangani Urban health area, from July to December 2021. It shows that men (59%) have adhered more than women (41%). People aged 18-54 were vaccinated (59%) more than those aged 55 and over (41%). 71 of those vaccinated (2%) had no co-morbidity. An overall acceptance of 64.7% was observed, with a gradient of 77.8% among medical professionals, 52.2% among nurses and 37.2% among nursing assistants. 11.4% of vaccinated health professionals and 85% of vaccinated persons did not return for the second dose. The Kisangani fiftieth anniversary hospital site recorded a drop-out rate of 93%. Minor IPD (0.3%) was observed among those vaccinated. Moderna was the most preferred/used vaccine (46%) and the Makiso-Kisangani General Reference Hospital site was the most used/attended (66.5%). The wastage rate was 12% (all antigens combined) of which 2 antigens (Astra Zeneca & Moderna) stood out at 21% and 13% respectively > 10% (Standard). The objective of this study is to present the mapping of vaccination in the province of Tshopo, DRC in the first half of the year (2021) of the introduction of vaccine against covid-19 in order to protect the population against this pandemic.